Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Teradata Corp
TDC
Dorian LPG
LPG
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
PTIX Protagenic Therapeutics
- 0.6615
- +0.0195+3.04%
Trading Dec 19 10:13 ET
4.49MMarket Cap-0.52P/E (TTM)
0.7000High0.6000Low119.09KVolume0.6250Open0.6420Pre Close76.29KTurnover2.05%Turnover RatioLossP/E (Static)6.79MShares1.870052wk High6.24P/B3.85MFloat Cap0.451552wk Low--Dividend TTM5.82MShs Float19.5600Historical High--Div YieldTTM15.58%Amplitude0.4515Historical Low0.6400Avg Price1Lot Size
About Protagenic Therapeutics Company
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Company Profile
SymbolPTIX
Company NameProtagenic Therapeutics
Listing DateApr 27, 2021
Issue Price4.50
Founded1994
CEODr. Garo H. Armen, PhD
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address149 Fifth Avenue,Suite 500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-212-994-8200
Websitehttp://www.protagenic.com
Company Executives
- Name
- Position
- Salary
- Andrew Slee
- Chief Operating Officer
- --
- Dr. Robert B. Stein, M.D.,PhD
- Director and Chief Medical Officer
- --
- Dr. Alexander K. Arrow, M.D.
- Chief Financial Officer
- 150.00K
- Dr. Garo H. Armen, PhD
- Executive Chairman of the Board and Principal Executive Officer
- --
- Dr. Jennifer S. Buell, PhD
- Director
- --
- Khalil Barrage
- Independent Director
- --
- Timothy R. Wright
- Lead Independent Director
- --
- Brian J. Corvese
- Independent Director
- --
